The DOI matches its Crossref record; 325 of the 325 references it cites were found in a registry or an index.
Gone to Pot – A Review of the Association between Cannabis and Psychosis
Open accessAbstract
Cannabis is the most commonly used illicit drug worldwide, with ~5 million daily users worldwide. Emerging evidence supports a number of associations between cannabis and psychosis/psychotic disorders, including schizophrenia. These associations-based on case-studies, surveys, epidemiological studies, and experimental studies indicate that cannabinoids can produce acute, transient effects; acute, persistent effects; and delayed, persistent effects that recapitulate the psychopathology and psychophysiology seen in schizophrenia. Acute exposure to both cannabis and synthetic cannabinoids (Spice/K2) can produce a full range of transient psychotomimetic symptoms, cognitive deficits, and psychophysiological abnormalities that bear a striking resemblance to symptoms of schizophrenia. In individuals with an established psychotic disorder, cannabinoids can exacerbate symptoms, trigger relapse, and have negative consequences on the course of the illness. Several factors appear to moderate these associations, including family history, genetic factors, history of childhood abuse, and the age at onset of cannabis use. Exposure to cannabinoids in adolescence confers a higher risk for psychosis outcomes in later life and the risk is dose-related. Individuals with polymorphisms of COMT and AKT1 genes may be at increased risk for psychotic disorders in association with cannabinoids, as are individuals with a family history of psychotic disorders or a history of childhood trauma. The relationship between cannabis and schizophrenia fulfills many but not all of the standard criteria for causality, including temporality, biological gradient, biological plausibility, experimental evidence, consistency, and coherence. At the present time, the evidence indicates that cannabis may be a component cause in the emergence of psychosis, and this warrants serious consideration from the point of view of public health policy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–325 of 325
Konings, M., Stefanis, N., Kuepper, R., de Graaf, R., ten Have, M., van Os, J., Bakoula, C., & Henquet, C. (2011) · Psychological Medicine · doi:10.1017/s0033291711000973 · Cited by 115
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study
Barkus, E., Morrison, P. D., Vuletic, D., Dickson, J. C., Ell, P. J., Pilowsky, L. S., Brenneisen, R., Holt, D. W., Powell, J. F., Kapur, S., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110382465 · Cited by 114
Generators of electrical and magnetic mismatch responses in humans
nen, R. N. T., & Alho, K. (1995) · Brain Topography · doi:10.1007/bf01195257 · Cited by 109
Type-1 Cannabinoid Receptor Signaling in Neuronal Development
Gaffuri, A.-L., Ladarré, D., & Lenkei, Z. (2012) · Pharmacology · doi:10.1159/000339075 · Cited by 108
Acute effects of THC on time perception in frequent and infrequent cannabis users
Sewell, R. A., Martin, A. M. S., Elander, J., Radhakrishnan, R., Williams, A. H., Skosnik, P. D., Pittman, B. P., Ranganathan, M., & D’Souza, D. C. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2915-6 · Cited by 108
Self-citationCerebellar activity and disturbed time sense after THC
Mathew, R. J., Wilson, W. H., Turkington, T. G., & Coleman, R. E. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00375-8 · Cited by 108
Estrada, G., Fatjó‐Vilas, M., Muñoz, M. J., Pulido, G., Miñano, M. J., Toledo, E. L., Illa, J. M., Martín, M., Miralles, M. L., Miret, S., et al. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01665.x · Cited by 107
Meschler, J. P., & Howlett, A. C. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00012-0 · Cited by 107
Timing dysfunctions in schizophrenia span from millisecond to several-second durations
Carroll, C. A., O’Donnell, B. F., Shekhar, A., & Hetrick, W. P. (2009) · Brain and Cognition · doi:10.1016/j.bandc.2009.02.001 · Cited by 107
Event-related Brain Potentials: A Window on Information Processing in Schizophrenia
Duncan, C. C. (1988) · Schizophrenia Bulletin · doi:10.1093/schbul/14.2.199 · Cited by 106
Leweke, F. M., Schneider, U., Thies, M., Münte, T. F., & Emrich, H. M. (1999) · Psychopharmacology · doi:10.1007/s002130050884 · Cited by 102
Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis
Dragt, S., Nieman, D. H., Schultze-Lutter, F., van der Meer, F., Becker, H. E., de Haan, L., Dingemans, P. M. A. J., Birchwood, M. J., Patterson, P. H., Salokangas, R. K. R., et al. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01763.x · Cited by 101
Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend.
Stefanis, N., Dragovic, M., Power, B., Jablensky, A., Castle, D., & Morgan, V. (2013) · Schizophrenia bulletin · doi:10.1093/schbul/sbs188 · Cited by 101
Hickman, M., Vickerman, P. T., Macleod, J., Kirkbride, J. B., & Jones, P. B. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01710.x · Cited by 101
Neuropsychological consequences of regular marijuana use: a twin study
Lyons, M. J., Bar, J. L., Panizzon, M. S., Toomey, R., Eisen, S. A., Xian, H., & Tsuang, M. T. (2004) · Psychological Medicine · doi:10.1017/s0033291704002260 · Cited by 100
Every‐Palmer, S. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03119.x · Cited by 99
D’Souza, D. C. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78010-2 · Cited by 98
Self-citationD’Souza, D. C., Fridberg, D. J., Skosnik, P. D., Williams, A. H., Roach, B. J., Singh, N. M., Carbuto, M., Elander, J., Martin, A. M. S., Pittman, B. P., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.8 · Cited by 98
Self-citationCannabis psychosis following bhang ingestion
Chaudry, H. R., Moss, H. B., BASHIR, A., et al. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01874.x · Cited by 98
Moreau, J., & Peters, H. J. (1973) · Cited by 95
Duncan, A. E., Sartor, C. E., Scherrer, J. F., Grant, J. D., Heath, A. C., Nelson, E. C., Jacob, T., & Bucholz, K. K. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02210.x · Cited by 94
AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic Disorder
the Genetic Risk and Outcome of Psychosis (GROUP) Investigators, van Winkel, R., Genetic Risk and Outcome of Psychosis (GROUP) Investigators, van Beveren, N. J. M., & Simons, C. J. P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.141 · Cited by 94
Koethe, D., Gerth, C. W., Neatby, M. A., Haensel, A., Thies, M., Schneider, U., Emrich, H. M., Klosterkötter, J., Schultze-Lutter, F., & Leweke, F. M. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.07.023 · Cited by 93
Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation
Pistis, M., Porcu, G. S., Melis, M., Diana, M., & Gessa, G. L. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01612.x · Cited by 92
Kuepper, R., Ceccarini, J., Lataster, J., van Os, J., van Kroonenburgh, M. J. P. G., van Gerven, J., Marcelis, M. C., Laere, K. V., & Henquet, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070378 · Cited by 92
Residual neuropsychologic effects of cannabis
Pope, H. G., Gruber, A. J., & Yurgelun-Todd, D. A. (2001) · Current Psychiatry Reports · doi:10.1007/s11920-001-0045-7 · Cited by 92
Neuregulin 1 Genotype and Schizophrenia
Munafo, M. R., Attwood, A. S., & Flint, J. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm129 · Cited by 89
Gage, S. H., Zammit, S., & Hickman, M. (2013) · F1000 Medicine Reports · doi:10.3410/m5-2 · Cited by 88
Vearrier, D., & Osterhoudt, K. C. (2010) · Pediatric Emergency Care · doi:10.1097/pec.0b013e3181e4f416 · Cited by 87
Roser, P., Juckel, G., Rentzsch, J., Nadulski, T., Gallinat, J., & Stadelmann, A. M. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.04.008 · Cited by 87
Effects of interval duration on temporal processing in schizophrenia
Davalos, D. B., Kisley, M. A., & Ross, R. G. (2003) · Brain and Cognition · doi:10.1016/s0278-2626(03)00157-x · Cited by 87
Sewell, R. A., Ranganathan, M., & D’Souza, D. C. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782802 · Cited by 86
Self-citationCannabis, Cognition, and Residual Confounding
Pope, H. G. (2002) · JAMA · doi:10.1001/jama.287.9.1172 · Cited by 84
Hooker, W. D., & Jones, R. T. (1987) · Psychopharmacology · doi:10.1007/bf00690920 · Cited by 82
Kempel, P., Lampe, K., Parnefjord, R., Hennig, J., & Kunert, H. J. (2003) · Neuropsychobiology · doi:10.1159/000072884 · Cited by 82
Minozzi, S., Davoli, M., Bargagli, A. M., Amato, L., Vecchi, S., & Perucci, C. A. (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2009.00132.x · Cited by 80
Arendt, M. C. B. B., Mortensen, P. B., Rosenberg, R., Pedersen, C. B., & Waltoft, B. L. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.11.1269 · Cited by 80
Psychosis‐inducing effects of cannabis are related to both childhood abuse and COMT genotypes
Alemany, S., Arias, B., Fatjó‐Vilas, M., Villa, H., Moya-Higueras, J., Ibáñez, M. I., Ortet, G., Gastó, C., & Fañanás, L. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12108 · Cited by 78
Effects of Regular Marijuana Use on Sexual Performance
Halikas, J. A., Weller, R. A., & Morse, C. L. (1982) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1982.10471911 · Cited by 78
Reduced binocular depth inversion in regular cannabis users
Semple, D. M., Ramsden, F., & McIntosh, A. M. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00140-0 · Cited by 78
Marks, D. F., & MacAvoy, M. G. (1989) · Psychopharmacology · doi:10.1007/bf00445566 · Cited by 77
Clinical characteristics of adolescents later hospitalized for schizophrenia
Weiser, M., Knobler, H. Y., Noy, S., & Kaplan, Z. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10647 · Cited by 77
Cannabis use, cognition and brain structure in first-episode psychosis
Cunha, P. J., Rosa, P. G. P., Ayres, A. M., Duran, F., Santos, L. C., Scazufca, M., Menezes, P. R., dos Santos, B., Murray, R. M., Crippa, J. A. S., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.04.009 · Cited by 77
Cannabinoid modulation of time estimation in the rat.
Han, C. J., & Robinson, J. K. (2001) · Behavioral Neuroscience · doi:10.1037/0735-7044.115.1.243 · Cited by 73
Griffith‐Lendering, M. F. H., Huijbregts, S. C. J., Mooijaart, A., Vollebergh, W., & Swaab, H. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.024 · Cited by 71
Compton, M. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.01.005 · Cited by 71
Cannabinoid Modulations of Resting State EEG Theta Power and Working Memory Are Correlated in Humans
Böcker, K. B. E., Hunault, C. C., Gerritsen, J., Kruidenier, M., Mensinga, T. T., & Kenemans, J. L. (2009) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2009.21355 · Cited by 71
Moore, E., Mancuso, S. G., Slade, T. N., Galletly, C. A., & Castle, D. J. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412443900 · Cited by 69
Vinkers, C., van Gastel, W., Schubart, C., van Eijk, K., Luykx, J., van Winkel, R., Joëls, M., Ophoff, R., Boks, M., Bruggeman, R., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.020 · Cited by 69
Cannabis users have higher premorbid IQ than other patients with first onset psychosis
Ferraro, L., Russo, M., O’Connor, J. A., Wiffen, B. D. R., Falcone, M. A., Sideli, L., Gardner-Sood, P., Stilo, S. A., Trotta, A., Dazzan, P., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.046 · Cited by 68
Costas, J., Sanjuán, J., Ramos‐Ríos, R., Paz, E., Agra, S., Tolosa, A., Páramo, M., Brenlla, J., & Arrojo, M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.01.014 · Cited by 68
HARDING, T. W. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.04200050048008 · Cited by 67
Forty-Six Cases of Psychosis in Cannabis Abusers Gunila Bernhardson
Gunne, L. M. (1972) · International Journal of the Addictions · doi:10.3109/10826087209026757 · Cited by 66
Physicians and Medical Marijuana
Kleber, H. D., & DuPont, R. L. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12030373 · Cited by 65
Psychiatric Sequelae of Spice, K2, and Synthetic Cannabinoid Receptor Agonists
Benford, D. M., & Caplan, J. P. (2011) · Psychosomatics · doi:10.1016/j.psym.2011.01.004 · Cited by 65
Decoster, J., van Os, J., Kenis, G., Henquet, C., Peuskens, J., Binder, M. D., & van Winkel, R. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31174 · Cited by 65
Juckel, G., Roser, P., Nadulski, T., Stadelmann, A. M., & Gallinat, J. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.08.015 · Cited by 64
Marijuana and memory impairment: Effect on free recall and recognition memory
Miller, L. L., McFarland, D. J., Cornett, T., & Brightwell, D. R. (1977) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(77)90191-5 · Cited by 62
Uchiyama, N., Kikura‐Hanajiri, R., & Goda, Y. (2011) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.59.1203 · Cited by 62
Reduced binocular depth inversion as an indicator of cannabis-induced censorship impairment
Emrich, H. M., Weber, M. M., Wendl, A., Zihl, J., Meyer, L., & Hanisch, W. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90383-d · Cited by 62
DSM-V Research Agenda: Substance Abuse/Psychosis Comorbidity
Rounsaville, B. J. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm054 · Cited by 62
The effect of cannabis use and gender on the visual steady state evoked potential.
Skosnik, P., Krishnan, G., Vohs, J., & O'Donnell, B. (2006) · Clinical Neurophysiology · doi:10.1016/j.clinph.2005.09.024 · Cited by 62
Spice: A Legal Marijuana Equivalent
Johnson, L. A., Johnson, R. L., & Alfonzo, C. (2011) · Military Medicine · doi:10.7205/milmed-d-10-00356 · Cited by 60
Central nervous system effects of haloperidol on THC in healthy male volunteers
Liem-Moolenaar, M., Beek, E. T. T., de Kam, M. L., Franson, K. L., Kahn, R. S., Hijman, R., Touw, D. J., & van Gerven, J. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109358200 · Cited by 60
Gene-Environment Interactions Underlying the Effect of Cannabis in First Episode Psychosis
Pelayo‐Terán, J. M., Suárez‐Pinilla, P., Chadi, N., & Crespo‐Facorro, B. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884609 · Cited by 60
Psychosis after cannabis abuse.
Carney, M. W. P., BACELLE, L., & Robinson, B. M. (1984) · BMJ · doi:10.1136/bmj.288.6423.1047 · Cited by 59
Avoidable cancer deaths globally
Brawley, O. W. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20108 · Cited by 59
Boydell, J. E., Dean, K., Dutta, R., Γιουρούκου, Έ., Fearon, P., & Murray, R. M. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.03.014 · Cited by 59
Compton, M. T., Broussard, B., Ramsay, C. E., & Stewart, T. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.10.005 · Cited by 58
Minango, J. (1989) · British Journal of Addiction · doi:10.1111/j.1360-0443.1989.tb00576.x · Cited by 58
Wylie, A. S., Scott, R. T., & Burnett, S. J. (1995) · BMJ · doi:10.1136/bmj.311.6997.125 · Cited by 58
Cannabis use disorder and age at onset of psychosis — A study in first-episode patients
SCHIMMELMANN, B. G., Conus, P., Cotton, S., Kupferschmid, S., Karow, A., Schultze‐Lutter, F., McGorry, P. D., & Lambert, M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.03.023 · Cited by 56
The Effect of Chronic Cannabinoids on Broadband EEG Neural Oscillations in Humans
Skosnik, P. D., D’Souza, D. C., Steinmetz, A. B., Edwards, C. R., Vollmer, J. M., Hetrick, W. P., & O’Donnell, B. F. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.65 · Cited by 55
Self-citationCannabis Psychosis and Acute Schizophrenia
Basu, D., Malhotra, A. K., Bhagat, A., & Varma, V. K. (1999) · European Addiction Research · doi:10.1159/000018968 · Cited by 54
Does olanzapine inhibit the psychomimetic effects of Δ 9 -tetrahydrocannabinol?
Kleinloog, D., Liem-Moolenaar, M., Jacobs, G. E., Klaassen, E. S., de Kam, M., Hijman, R., & van Gerven, J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112446534 · Cited by 53
Neuropsychological Assessment of Undergraduate Marihuana and LSD Users
Culver, C. M., & King, F. W. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760170093015 · Cited by 53
Effects of cannabis use status on cognitive function, in males with schizophrenia
Rabin, R. A., Zakzanis, K. K., Daskalakis, Z. J., & George, T. P. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.11.019 · Cited by 52
(2002) · HRB National Drugs Library (Health Research Board) · Cited by 50
Antiemetic Effect of Intramuscular Levonantradol in Patients Receiving Anticancer Chemotherapy
Cronin, C. M., Sallan, S. E., Gelber, R. D., Lucas, V. S., & László, J. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02572.x · Cited by 50
Reduction of Auditory P50 Gating Response in Marihuana Users: Further Supporting Data
Patrick, G., & Struve, F. A. (2000) · Clinical Electroencephalography · doi:10.1177/155005940003100207 · Cited by 50
Rentzsch, J., Penzhorn, A., KERNBICHLER, K., Plöckl, D., de Castro, A. G.-C., Gallinat, J., & Jockers-Scherübl, M. C. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.02.004 · Cited by 48
Sensory gating impairments in heavy cannabis users are associated with altered neural oscillations.
Edwards, C. R., Skosnik, P. D., Steinmetz, A. B., O’Donnell, B. F., & Hetrick, W. P. (2009) · Behavioral Neuroscience · doi:10.1037/a0016328 · Cited by 48
Cannabis use in a large sample of acute psychiatric admissions
MATHERS, D. C., Ghodse, A. H., CAAN, A. W., et al. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb03104.x · Cited by 47
Time Estimation by Healthy Subjects and Schizophrenic Patients: A Methodological Study
Tysk, L. (1983) · Perceptual and Motor Skills · doi:10.2466/pms.1983.56.3.983 · Cited by 47
Morrison, P. D., & Stone, J. M. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1166 · Cited by 47
Changing incidence of psychotic disorders among the young in Zurich
Ajdacic‐Gross, V., Lauber, C., Warnke, I., Haker, H., Murray, R. M., & Wulf Rössler, A. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.06.001 · Cited by 45
Leweke, F. M., Kampmann, C., Radwan, M., Dietrich, D. E., Johannes, S., Emrich, H. M., & Münte, T. F. (1998) · Neuropsychobiology · doi:10.1159/000026487 · Cited by 44
Levonantradol for Chemotherapy‐Induced Emesis: Phase I—II Oral Administration
László, J., Lucas, V. S., Hanson, D., Cronin, C. M., & Sallan, S. E. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02573.x · Cited by 44
McClure, G. Y., & McMillan, D. E. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36710-2 · Cited by 43
Dissanayake, D. W. N., Zachariou, M., Marsden, C. A., & Mason, R. J. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.039 · Cited by 41
Panic Attack after Spice Abuse in a Patient with ADHD
Müller, H., Huttner, H. B., Köhrmann, M., Wielopolski, J., Kornhuber, J., & Sperling, W. (2010) · Pharmacopsychiatry · doi:10.1055/s-0029-1243252 · Cited by 40
Affect processing and positive syndrome schizotypy in cannabis users
Skosnik, P. D., Park, S., Dobbs, L., & Gardner, W. L. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2007.02.010 · Cited by 40
Patrick, G., Straumanis, J. J., Struve, F. A., Fitz-Gerald, M. J., Leavitt, J., & Manno, J. E. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00155-3 · Cited by 40
Kantrowitz, J. T., Nolan, K. A., Sen, S., Simen, A. A., Lachman, H. M., & Bowers, M. B. (2009) · Psychiatric Quarterly · doi:10.1007/s11126-009-9108-4 · Cited by 39
de Sola, S., Tarancón, T., Peña‐Casanova, J., Espadaler, J. M., Langohr, K., Poudevida, S., Farré, M., Verdejo‐García, A., & de la Torre, R. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1217-5 · Cited by 39
Quinones, F. H., Haerens, M., & Christie, L. (2012) · Cited by 39
Psychopharmacological effects of cannabis.
Johnson, B. A. (1990) · PubMed · Cited by 38
Wig, N. N., & Vk, V. (1977) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(77)90028-x · Cited by 38
Ruíz-Veguilla, M., Barrigón, M. L., Hernández, L., Rubio, J. L., Gurpegui, M., Sarramea, F., Cervilla, J. A., Gutiérrez, B., James, A. C., & Ferrín, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.03.003 · Cited by 38
Kaufmann, R. M., Kraft, B., Frey, R., Winkler, D., Weiszenbichler, S., Bäcker, C., Kasper, S. F., & Kress, H. G. (2009) · Pharmacopsychiatry · doi:10.1055/s-0029-1237397 · Cited by 36
Spencer, D. J. (1971) · International Journal of the Addictions · doi:10.3109/10826087109057790 · Cited by 36
Subjective Effects of Cannabis Before the First Psychotic Episode
Peters, B. D., de Koning, P. P., Dingemans, P. M. A. J., Becker, H. E., LINSZEN, D. H., & de Haan, L. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903179095 · Cited by 36
Studies on Psycho-Clinical Aspects of Long-Term Marihuana Use in 124 Cases
Chopra, G. S. (1973) · International Journal of the Addictions · doi:10.3109/10826087309033103 · Cited by 36
Psychosis and Cannabis Abuse in the Gambia: A Case-Control Study
Rolfe, M., Tang, C., Sabally, S., Todd, J., Sam, E. B., & N'jie, A. B. H. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.163.6.798 · Cited by 35
Sánchez-Torres, A. M., Basterra, V., Rosa, A., Fañanás, L., Zarzuela, A., Ibáñez, B., Peralta, V., & Cuesta, M. J. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0404-5 · Cited by 35
Wesnes, K. A., Annas, P., Edgar, C. J., Deeprose, C., Karlsten, R., Philipp, A., Kalliomäki, J., & Segerdahl, M. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109105900 · Cited by 35
Rentzsch, J., Buntebart, E., Stadelmeier, A., Gallinat, J., & Jockers-Scherübl, M. C. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.05.011 · Cited by 33
Auditory mismatch negativity deficits in long-term heavy cannabis users
Roser, P., Della, B., Norra, C., Uhl, I., Brüne, M., & Juckel, G. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0097-y · Cited by 32
Aggarwal, M., Banerjee, A., Singh, S. M., Mattoo, S. K., & Basu, D. (2012) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2011.11.008 · Cited by 30
Chronic Effects of Cannabis Use on the Auditory Mismatch Negativity
Greenwood, L., Broyd, S. J., Croft, R. J., Todd, J., Michie, P. T., Johnstone, S. J., Murray, R. M., & Solowij, N. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.035 · Cited by 27
Delayed preattentional functioning in early psychosis patients with cannabis use
Pesa, N., Hermens, D. F., Battisti, R. A., Kaur, M., Hickie, I. B., & Solowij, N. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2676-2 · Cited by 25
Johnson, B., Smith, B., & Taylor, P. J. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91389-x · Cited by 25
Citron, M. L., Ts, H., Vreeland, F., Krasnow, S. H., Fossieck, B. E., Harwood, S., Franklin, R., & Mh, C. (1985) · PubMed · Cited by 23
Non-replication of interaction between cannabis use and trauma in predicting psychosis
Kuepper, R., Henquet, C., Lieb, R., Wïttchen, H., & van Os, J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.012 · Cited by 23
Metabolic studies of drugs of abuse.
Volkow, N. D., Fowler, J. S., Wolf, A. P., & Gillespi, H. (1990) · PubMed · Cited by 23
Stambaugh, J. E., McAdams, J., & Vreeland, F. (1984) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1984.tb02756.x · Cited by 22
Oral Levonantradol in the Treatment of Chemotherapy‐Induced Emesis: Preliminary Observations
Diasio, R. B., Ettinger, D. S., & SATTERWHITE, B. E. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02579.x · Cited by 22
Heim, M., Römer, W., & Queißer, W. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02580.x · Cited by 21
Sheidler, V. R., Ettinger, D. S., Diasio, R. B., Enterline, J. P., & Brown, M. D. (1984) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1984.tb01824.x · Cited by 20
Heim, M. E., Quei�er, W., & Altenburg, H.-P. (1984) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00257128 · Cited by 18
Addy, P. H., Radhakrishnan, R., Cortés, J. A., & D’Souza, D. C. (2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.2.140 · Cited by 17
Self-citationZachariou, M., Dissanayake, D. W. N., Coombes, S., Owen, M. R., & Mason, R. J. (2008) · Cognitive Neurodynamics · doi:10.1007/s11571-008-9050-4 · Cited by 16
Psychosis Associated With Medical Marijuana: Risk vs. Benefits of Medicinal Cannabis Use
Pierre, J. M. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09121762 · Cited by 14
THE CANNABIS AND PSYCHOSIS CONNECTION QUESTIONED: A COMMENT ON FERGUSSON ET AL. 2005
MIRKEN, B., & Earleywine, M. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01117.x · Cited by 10
The effects of endocannabinoid signaling on network activity in developing and motor circuits
Wenner, P. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12068 · Cited by 7
Cited by
Owen, M. J., Sawa, A., & Mortensen, P. B. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01121-6 · Cited by 1,870
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Volkow, N. D., Swanson, J. M., Evins, A. E., DeLisi, L. E., Meier, M. H., Gonzalez, R., Bloomfield, M. A. P., Curran, H. V., & Baler, R. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3278 · Cited by 867
Sommermeyer, D., Hudecek, M., Kosasih, P. L., Gogishvili, T., Maloney, D. G., Turtle, C. J., & Riddell, S. R. (2016) · Leukemia · doi:10.1038/leu.2015.247 · Cited by 867
Acute and Chronic Effects of Cannabinoids on Human Cognition—A Systematic Review
Broyd, S. J., van Hell, H. H., Beale, C., Yücel, M., & Solowij, N. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.12.002 · Cited by 674
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations
Fischer, B., Russell, C., Sabioni, P., van den Brink, W., Le Foll, B., Hall, W., Rehm, J., & Room, R. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303818 · Cited by 433
Metadata
- Authors
- Radhakrishnan, R., Wilkinson, S. T., & D’Souza, D. C.
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2014-05-22
- Volume
- 5
- Pages
- 54-54
- ISSN
- 1664-0640 (ISSN-L)
- OpenAlex
- W2040750242
- Cited by
- 310
- References
- 325
- FWCI
- 24.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.